These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2386902)

  • 1. Survival of patients with ovarian cancer. Apart from stage and grade, tumor progesterone receptor content is a prognostic indicator.
    Slotman BJ; Nauta JJ; Rao BR
    Cancer; 1990 Aug; 66(4):740-4. PubMed ID: 2386902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of steroid receptors and aromatase activity in the prognosis of ovarian cancer: high tumor progesterone receptor levels correlate with longer survival.
    Slotman BJ; Kühnel R; Rao BR; Dijkhuizen GH; de Graaff J; Stolk JG
    Gynecol Oncol; 1989 Apr; 33(1):76-81. PubMed ID: 2703171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progesterone receptors in ovarian cancer.
    Harding M; Cowan S; Hole D; Cassidy L; Kitchener H; Davis J; Leake R
    Cancer; 1990 Feb; 65(3):486-91. PubMed ID: 2297640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid hormone receptors and long term survival in invasive ovarian cancer.
    Münstedt K; Steen J; Knauf AG; Buch T; von Georgi R; Franke FE
    Cancer; 2000 Oct; 89(8):1783-91. PubMed ID: 11042574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Steroid hormone receptors in ovarian carcinomas and their clinical significance].
    Geyer H; Teufel G; de Gregorio G; Pfleiderer A
    Onkologie; 1984 May; 7 Suppl 2():44-52. PubMed ID: 6379538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer.
    Lee P; Rosen DG; Zhu C; Silva EG; Liu J
    Gynecol Oncol; 2005 Mar; 96(3):671-7. PubMed ID: 15721410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid receptor content in human ovarian tumors: survival of patients with ovarian carcinoma related to steroid receptor content.
    Iversen OE; Skaarland E; Utaaker E
    Gynecol Oncol; 1986 Jan; 23(1):65-76. PubMed ID: 3943754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of hormonal receptor status of malignant ovarian tumors.
    Tkalia IG; Vorobyova LI; Svintsitsky VS; Nespryadko SV; Goncharuk IV; Lukyanova NY; Chekhun VF
    Exp Oncol; 2014 Jun; 36(2):125-33. PubMed ID: 24980769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of estrogen receptor and progesterone receptor status in young Chinese ovarian carcinoma patients.
    Yang XY; Xi MR; Yang KX; Yu H
    Gynecol Oncol; 2009 Apr; 113(1):99-104. PubMed ID: 19178934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinoma.
    Sevelda P; Denison U; Schemper M; Spona J; Vavra N; Salzer H
    Br J Obstet Gynaecol; 1990 Aug; 97(8):706-12. PubMed ID: 2400748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors.
    Chadha S; Rao BR; Slotman BJ; van Vroonhoven CC; van der Kwast TH
    Hum Pathol; 1993 Jan; 24(1):90-5. PubMed ID: 8418017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the contribution of immunologically-detectable HER2, steroid receptors and of the "triple-negative" tumor status to disease-free and overall survival of women with epithelial ovarian cancer.
    de Toledo MC; Sarian LO; Sallum LF; Andrade LL; Vassallo J; de Paiva Silva GR; Pinto GA; Soares FA; Fonseca CD; Derchain SF
    Acta Histochem; 2014 Apr; 116(3):440-7. PubMed ID: 24238473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study.
    Cardillo MR; Petrangeli E; Aliotta N; Salvatori L; Ravenna L; Chang C; Castagna G
    J Exp Clin Cancer Res; 1998 Jun; 17(2):231-7. PubMed ID: 9700586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between steroid hormone receptors, histological and clinical parameters in ovarian carcinoma.
    Anderl P; Fuith LC; Daxenbichler G; Marth C; Dapunt O
    Gynecol Obstet Invest; 1988; 25(2):135-40. PubMed ID: 3371761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of steroid hormone receptors for 5-year survival in stage II endometrial cancer.
    Friberg LG; Norén H
    Cancer; 1993 Jun; 71(11):3570-4. PubMed ID: 8490906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male breast cancer: Looking for better prognostic subgroups.
    Abreu MH; Afonso N; Abreu PH; Menezes F; Lopes P; Henrique R; Pereira D; Lopes C
    Breast; 2016 Apr; 26():18-24. PubMed ID: 27017238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications.
    Rambau P; Kelemen LE; Steed H; Quan ML; Ghatage P; Köbel M
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between progesterone receptor expression and survival in women with adult granulosa cell tumors.
    Puechl AM; Edwards J; Suri A; Nakayama J; Bean S; Gehrig P; Saks E; Duska L; Broadwater G; Ehrisman J; Horowitz N; Secord AA
    Gynecol Oncol; 2019 Apr; 153(1):74-79. PubMed ID: 30661765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.